Wed 30 June |
|
DAY 1 | Conference Room | Workshop Room |
|
DAY 1 | Conference Room | Workshop Room |
| ||
9:00 | WuXi AppTec Workshop - New technologies for target discovery and validation Abstract - library screen platform propelled by various new technologies, and extension to the challenging field of immunology, as well...[More] |
9:00: | |||
9:05: | 9:05: | ||||
9:10: | 9:10: | ||||
9:15: | 9:15: | ||||
9:20: | 9:20: | ||||
9:25: | 9:25: | ||||
9:30: | 9:30: | ||||
9:35: | 9:35: | ||||
9:40: | 9:40: | ||||
9:45: | 9:45: | ||||
9:50: | 9:50: | ||||
9:55: | 9:55: | ||||
10:00 | Welcome & Introductions Chairs: Rachel Lambert-Forsyth, British Pharmacological Society Sanj Kumar, ELRIG |
10:00 | |||
10:05 | 10:05 | ||||
10:10 | Keynote Speaker Chairs: Katie Chapman, MSD
Artios Pharma – targeting DNA repair vulnerabilities in cancer 10:10 (50 mins) Keynote Speaker: Simon Boulton, Artios Pharma/Senior Group Leader, Francis Crick Institute. |
10:10 | |||
10:15 | 10:15 | ||||
10:20 | 10:20 | ||||
10:25 | 10:25 | ||||
10:30 | 10:30 | ||||
10:35 | 10:35 | ||||
10:40 | 10:40 | ||||
10:45 | 10:45 | ||||
10:50 | 10:50 | ||||
10:55 | 10:55 | ||||
11:00 | Refreshment break | 11:00 | |||
11:05 | 11:05 | ||||
11:10 | Target ID & Validation Chairs: Michael Howell, The Francis Crick Institute Sam Groom, University of Bath Session Chair Welcome 11:10 (5 mins) Michael Howell, The Francis Crick Institute Sam Groom, University of Bath Using Genetics and Genomics to Drive Drug Discovery and Development 11:15 (25 mins) Victor Neduva, MSD
Early identification of target candidates for pancreatic adenocarcinoma immunotherapy 11:40 (30 mins) Olaf Hardt — Miltenyi Biotec Daniel Schäfer — Miltenyi Biotec Hit and Run: a rapid route to new target ID with PROTEINi 12:10 (25 mins) Benedict Cross, PhoreMost |
11:10 | |||
11:15 | 11:15 | ||||
11:20 | 11:20 | ||||
11:25 | 11:25 | ||||
11:30 | 11:30 | ||||
11:35 | 11:35 | ||||
11:40 | 11:40 | ||||
11:45 | 11:45 | ||||
11:50 | 11:50 | ||||
11:55 | 11:55 | ||||
12:00 | 12:00 | ||||
12:05 | 12:05 | ||||
12:10 | 12:10 | ||||
12:15 | 12:15 | ||||
12:20 | 12:20 | ||||
12:25 | 12:25 | ||||
12:30 | 12:30 | ||||
12:35 | 12:35 | ||||
12:40 | 12:40 | ||||
12:45 | 12:45 | ||||
12:50 | Refreshment Break | Miltenyi Biotec Miltenyi Hot Topic Workshop - • Issue re Tissues When the tissue is the issue: tips and tricks for successful single cell sequencing The reliability and quality of any genomic analysis starts with ...[More] |
12:50 | ||
12:55 | 12:55 | ||||
1:00 | 1:00: | ||||
1:05: | 1:05: | ||||
1:10: | 1:10: | ||||
1:15: | 1:15: | ||||
1:20: | 1:20: | ||||
1:25: | 1:25: | ||||
1:30: | 1:30: | ||||
1:35: | 1:35: | ||||
1:40: | 1:40: | ||||
1:45: | 1:45: | ||||
1:50: | 1:50: | ||||
1:55: | 1:55: | ||||
2:00 | 2:00: | ||||
2:05: | 2:05: | ||||
2:10: | 2:10: | ||||
2:15: | 2:15: | ||||
2:20: | 2:20: | ||||
2:25: | 2:25: | ||||
2:30: | Target ID & Validation Chairs: Michael Howell, The Francis Crick Institute Sam Groom, University of Bath Identification of novel therapeutics for fibrotic diseases using phenotypic screening 14:30 (20 mins) Selim Cellek, Anglia Ruskin University
Single-cell CRISPR screens in primary human T cells 14:50 (15 mins) Tilmann Buerckstuemmer — Aelian Biotechnology Using automated methods to quantify both efficacy and toxicity of compounds for drug development using the nematode worm Caenorhabditis elegans 15:05 (20 mins) David Weinkove, Magnitude Biosciences Ltd |
2:30: | |||
2:35: | 2:35: | ||||
2:40: | 2:40: | ||||
2:45: | 2:45: | ||||
2:50: | 2:50: | ||||
2:55: | 2:55: | ||||
3:00 | 3:00: | ||||
3:05: | 3:05: | ||||
3:10: | 3:10: | ||||
3:15: | 3:15: | ||||
3:20: | 3:20: | ||||
3:25: | Refreshment Break | 3:25: | |||
3:30: | 3:30: | ||||
3:35: | 3:35: | ||||
3:40: | Routes to Funding Session Chairs: Ian Tomlinson, Apollo Therapeutics Routes to Funding Panel Discussion 15:40 (5 mins) Ian Tomlinson, Apollo Therapeutics Perspectives on Grant Funding & Technology Transfer 15:45 (10 mins) Paul Mercer, The Francis Crick institute Perspectives on Venture Capital 15:55 (10 mins) Helen Philippou, University of Leeds Perspectives on Consortia & Industry Collaboration 16:05 (10 mins) Julie Brady, University of Dundee - Drug Discovery Unit Perspectives on Novel Routes to Translation 16:15 (10 mins) Nadine Clemo, Apollo Therapeutics |
3:40: | |||
3:45: | 3:45: | ||||
3:50: | 3:50: | ||||
3:55: | 3:55: | ||||
4:00 | 4:00: | ||||
4:05: | 4:05: | ||||
4:10: | 4:10: | ||||
4:15: | 4:15: | ||||
4:20: | 4:20: | ||||
4:25: | 4:25: | ||||
4:30: | 4:30: | ||||
4:35: | 4:35: | ||||
4:40: | 4:40: | ||||
4:45: | 4:45: | ||||
4:50: | 4:50: | ||||
4:55: | 4:55: | ||||
5:00 | 5:00: | ||||
5:05: | 5:05: | ||||
5:10: | Day 1 Closing Remarks Chairs: Michael Howell, The Francis Crick Institute Sam Groom, University of Bath |
5:10: | |||
5:15: | 5:15: | ||||
5:20: | Scientific recruitment consultant Emma Howarth (Langton Howarth) gives the lowdown on how to write the perfect CV to help you land your next job, with live Q&A 17:20 (30 mins) Emma Howarth, Langton Howarth |
5:20: | |||
5:25: | 5:25: | ||||
5:30: | 5:30: | ||||
5:35: | 5:35: | ||||
5:40: | 5:40: | ||||
5:45: | 5:45: | ||||
5:50: | 5:50: | ||||
5:55: | 5:55: | ||||
6:00 | 6:00: |